F. Scolari et al., CHOLESTEROL ATHEROMATOUS EMBOLISM - AN INCREASINGLY RECOGNIZED CAUSE OF ACUTE-RENAL-FAILURE, Nephrology, dialysis, transplantation, 11(8), 1996, pp. 1607-1612
Background. Cholesterol atheromatous embolism is a systemic disease re
sulting from cholesterol crystal embolization to many organs, includin
g the kidney. Vascular surgery, vascular radiology investigations and
anticoagulation have been identified as inciting factors. Methods. Fif
teen patients with extensive atherosclerosis, presenting with simultan
eous occurrence of acute renal failure and peripheral ischaemic change
s were diagnosed as having acute renal failure due to cholesterol athe
romatous embolism. Results. The patients, 12 men and three women, had
an average age of 65 years. In one patient, spontaneous occurrence of
the disease was observed. An inciting factor was identified in 14 pati
ents: aortography in 10, aortic surgery in two, and thrombolysis in tw
o. Clinical course of acute renal failure was quite variable. Four pat
ients required dialysis; 11 were conservatively managed. All patients
had concomitant skin lesions, including digital mottling, cyanosis and
gangrene of the toes, and livedo reticularis of the lower limb and ab
domen. Eosinophilia was the most common laboratory abnormality. The di
agnosis of cholesterol atheromatous embolism was confirmed by tissue e
xamination in eight; in three it was based on the finding of retinal c
holesterol emboli; in four patients it was made on clinical grounds. S
even patients died within 36 months. Death was most commonly from card
iac causes. Conclusions. Since the population at risk for cholesterol
embolism is growing and the disease is iatrogenic in origin, we should
expect to detect cholesterol embolism with greater frequency as cause
of acute renal failure in the future.